These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21803141)

  • 1. Effects of amphiphilic PCL-PEG-PCL copolymer addition on 5-fluorouracil release from biodegradable PCL films for stent application.
    Lu F; Lei L; Shen YY; Hou JW; Chen WL; Li YG; Guo SR
    Int J Pharm; 2011 Oct; 419(1-2):77-84. PubMed ID: 21803141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application: Drug release, microstructure, and ex vivo permeation behaviors.
    Lei L; Liu X; Guo S; Tang M; Cheng L; Tian L
    J Control Release; 2010 Aug; 146(1):45-53. PubMed ID: 20566400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCL films incorporated with paclitaxel/5-fluorouracil: Effects of formulation and spacial architecture on drug release.
    Rong HJ; Chen WL; Guo SR; Lei L; Shen YY
    Int J Pharm; 2012 May; 427(2):242-51. PubMed ID: 22349052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(epsilon-caprolactone) as drug carriers with enhanced properties.
    Zhang W; Li Y; Liu L; Sun Q; Shuai X; Zhu W; Chen Y
    Biomacromolecules; 2010 May; 11(5):1331-8. PubMed ID: 20405912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zero-order release of 5-fluorouracil from PCL-based films featuring trilayered structures for stent application.
    Lei L; Liu X; Shen YY; Liu JY; Tang MF; Wang ZM; Guo SR; Cheng L
    Eur J Pharm Biopharm; 2011 May; 78(1):49-57. PubMed ID: 21255648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatments of paclitaxel with poly(vinyl pyrrolidone) to improve drug release from poly(ɛ-caprolactone) matrix for film-based stent.
    Lu F; Shen YY; Shen YQ; Hou JW; Wang ZM; Guo SR
    Int J Pharm; 2012 Sep; 434(1-2):161-8. PubMed ID: 22643225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
    Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
    Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells.
    Hu Y; Xie J; Tong YW; Wang CH
    J Control Release; 2007 Mar; 118(1):7-17. PubMed ID: 17241684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites.
    Gong C; Wang C; Wang Y; Wu Q; Zhang D; Luo F; Qian Z
    Nanoscale; 2012 May; 4(10):3095-104. PubMed ID: 22535210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.
    Diab R; Hamoudeh M; Boyron O; Elaissari A; Fessi H
    Drug Dev Ind Pharm; 2010 Apr; 36(4):456-69. PubMed ID: 19877831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide-loaded biodegradable amphiphilic methoxy (poly ethylene glycol) and poly (epsilon caprolactone) copolymeric micelles as drug delivery vehicle for cancer therapy.
    Mohanty AK; Dilnawaz F; Mohanty C; Sahoo SK
    Drug Deliv; 2010 Jul; 17(5):330-42. PubMed ID: 20370380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel.
    Yang R; Meng F; Ma S; Huang F; Liu H; Zhong Z
    Biomacromolecules; 2011 Aug; 12(8):3047-55. PubMed ID: 21726090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric matrix for drug delivery: honokiol-loaded PCL-PEG-PCL nanoparticles in PEG-PCL-PEG thermosensitive hydrogel.
    Gou M; Gong C; Zhang J; Wang X; Wang X; Gu Y; Guo G; Chen L; Luo F; Zhao X; Wei Y; Qian Z
    J Biomed Mater Res A; 2010 Apr; 93(1):219-26. PubMed ID: 19557789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new insight for an old system: protein-PEG colocalization in relation to protein release from PCL/PEG blends.
    Liu KL; Widjaja E; Huang Y; Ng XW; Loo SC; Boey FY; Venkatraman SS
    Mol Pharm; 2011 Dec; 8(6):2173-82. PubMed ID: 22034836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute toxicity evaluation of in situ gel-forming controlled drug delivery system based on biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
    Fang F; Gong CY; Dong PW; Fu SZ; Gu YC; Guo G; Zhao X; Wei YQ; Qian ZY
    Biomed Mater; 2009 Apr; 4(2):025002. PubMed ID: 19208940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-poly(ε-caprolactone)-poly(ethylene glycol) graft copolymers: synthesis, self-assembly, and drug release behavior.
    Chen C; Cai G; Zhang H; Jiang H; Wang L
    J Biomed Mater Res A; 2011 Jan; 96(1):116-24. PubMed ID: 21105159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.